BioSpice logo

HOME  |  Presentations  |  Principal Investigators |  Publications
Reports & Documents  |  Seminars  |  Software


DARPA BioSpice Project
Progress Report
October 1, 2001-July 12, 2002

 
Jay Keasling
Chemical Engineering
University of California, Berkeley
 

The goal of our work is to develop high through-put genomic, proteomic, and metabolomic profiling of native, mutant, and engineered model microorganisms, namely Escherichia coli and Bacillus subtilis. The data from these complex profiles can then be analyzed and compared to computer simulations to predict complex microbial phenotypes under a number of different environmental conditions. To that end, we have developed DNA arrays for all 4,290 open reading frames in the E. coli genome and are currently developing similar arrays for B. subtilis. We are using the E. coli arrays to examine the response of the host to the introduction of heterologous metabolic pathways and to mutations in key regulatory genes. Finally, we are developing in vivo, fluorescent reporter systems to monitor the expression of multiple genes simultaneously. This system will allow us to deduce a cellular response cascade, such as that controlling sporulation in B. subtilis.

To test our arrays, we have engineered E. coli with a heterologous mevalonate pathway from Saccharomyces cerevisiae and tested its affect on expression of E. coli's native genes. In addition, we have monitored flux through the pathway by measuring endpoint of the heterologous metabolic pathway. We find that the heterologous metabolic pathways are highly expressed when induced (as evidenced by the green spots corresponding to the mevalonate pathway genes (pmk, idi, mk, mpd)) (Figures 1 and 2). While the expression of most of E. coli's native genes are expressed at the same level whether the mevalonate pathway genes are induced or not (as evidenced by the large number of yellow spots on the array), a select few of E. coli's native genes are down-regulated during induction of the mevalonate pathway (as evidenced by the red spots (yaaF, dxs)). These genes encode the enzymes for E. coli's non-mevalonate pathway.
 

Figure 1. Example DNA expression arrays of E. coli carrying the heterologous mevalonate pathway in the presence of inducer for the pathway and in the absence of inducer.

 

Figure 2. A plot of gene expression levels from Figure 1 during induction of the heterologous mevalonate pathway (Alexa 546 (green)) relative to the non-induced state (Alexa 647 (red)). Those data that fall on the straight line correspond to genes whose expression is relatively unchanged during induction. Those date that are significantly above the line correspond to genes that are highly expressed during induction, whereas those data below the line correspond to genes that are expressed more highly in the uninduced state than in the induced state.

 

To examine the effect of the heterologous pathway on metabolic flux and the flexibility of the metabolic network to perturbation, we measured the end-point of that metabolic pathway, namely production of an isoprenoid (Figure 3). With the engineered mevalonate pathway from S. cerevisiae, the engineered E. coli produced approximately an order of magnitude more lycopene than the strain with the native (DXP) pathway only. Incidentally, there is little difference in the growth rates of the two strains. This analysis indicates that there is a significant amount of flexibility in native metabolism. Finally, all analyses were performed in triplicate so that we have a good understanding of error in the metabolite profiles for modeling purposes.
 

Figure 3. Heterologous mevalonate pathway (red) and native pathway (green) and amounts of lycopene produced from the two pathways. The amount of lycopene produced from the heterologous pathway is nearly an order-of-magnitude higher than from the native pathway.

 

Conclusions. We have constructed DNA arrays for E. coli and tested them by assessing global cellular gene expression in a strain engineered with a heterologous metabolic pathway. In addition, we have shown that a metabolomics approach can be used to assess the flexibility of the bacterial metabolic network. Both types of analyses will be extremely important in assessing the response of E. coli and B. subtilis to a number of environmental conditions.

Future work. We are beginning to construct DNA arrays for all B. subtilis ORF's and will use these to study gene expression during the onset of sporulation. We also plan to assess metabolism in this bacterium.


[Top of page]

HOME  |  Presentations  |  Principal Investigators |  Publications
Reports & Documents  |  Seminars  |  Software

Last modified: July 22, 2002